Present review is dedicated to achievements and challenges of pharmacogenetics in modern medicine. Here one can find the data that is given Pharmacogenetic Working Group (EU) and FDA (USA) regarding to the value of pharmacogenetics tests during pharmacotherapy. The vast majority of information concerns psychotropic agents (antidepressants, antipsychotics, and narcotic analgesics), anticonvulsants, and anticancer medicines. Application of pharmacogenetics testing provides individual therapy of a patient that in turn will improve safety and increase the efficiency of pharmacotherapy of different diseases.
